Delivery Order SPE2DB22D1202-SPE2DB24FVBL1
Award Date 5/24/24
Potential Completion Date 5/28/24
Potential Value $1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award (SPE2DB20D1109|SPE2DB24FN81C) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order for $2,321.40 to supply MEDROXYPROGESTERONE 150 MG/ML medication. The contract is a firm fixed price with a completion date of March 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Medroxyprogesterone 150 mg/mL. The contract has a ceiling value of $1,511.15 and is a Firm Fixed Price Delivery Order, with a completion date of June 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MEDROXYPROGESTERONE 150 MG/ML. The contract, valued at $3,219.92, is a Firm Fixed Price Delivery Order with a completion date of September 20, 2024. No set-aside designation was used. AmerisourceBergen, through its Corporate Office division, has a long history of providing a wide range of pharmaceutical and medical products to...
- This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FNN77, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,627.84, and has an ultimate completion date of November 29, 2023. The contract is for the procurement of MEDROXYPROGESTERONE 150 MG/ML medical supplies, which are critical pharmaceuticals used in various healthcare applications....
- This federal contract award, valued at $1,585.89, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, with a period of performance through December 27, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Medroxyprogesterone 150 mg/mL. The Firm Fixed Price delivery order, valued at $1,504.84, was awarded on February 7, 2022 with a completion date of February 8, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,019.62 firm fixed price contract is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract has a completion date of January 22, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and related distribution...
- This federal contract award, with the ID SPE2DB20D6036|SPE2DB24FC8PE, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565315496 units of medroxyprogesterone 150 mg/ml, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $1,313.65 and an ultimate completion date of August 2, 2024. This contract award is not associated with any set-aside program....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide MEDROXYPROGESTERONE 150 MG/ML. The $2,802.66 contract has a completion date of February 27, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC allows...
- This federal contract award is for the delivery of medroxyprogesterone 150 mg/ml, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,567.50, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 3, 2024, with a completion date of September 4, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and...